How Policy Shifts and Demographics Are Reshaping Pakistan’s Drug Industry?
Pakistan’s pharmaceutical sector is undergoing a transformation. A combination of regulatory liberalization and long-term demographic trends is setting the stage for sustained growth, making it...
Can Pakistan’s local drugmakers outperform multinationals?
Pakistan’s pharmaceutical sector has entered a phase of structural transformation, and one question stands out: Can local drug manufacturers truly outperform multinational companies (MNCs)? Based...
Abbott’s comeback plan: why reintroduced drugs could boost future earnings?
Abbott Laboratories (Pakistan) Ltd, (ABOT) one of the country’s top multinational pharmaceutical players, is taking a bold step to reintroduce several previously discontinued products. This...
Is Haleon stock ready to soar on new Panadol variants?
In Pakistan’s evolving pharmaceutical landscape, few brands hold as dominant a position as Panadol. Now, Haleon Pakistan Ltd (HALEON) is doubling down on this flagship...
Following solid earnings, can PABC continue rising in 2025?
Pakistan Aluminium Beverage Cans Limited (PABC), the country’s first and only manufacturer and exporter of aluminium beverage cans, reported a resilient performance for CY24 and...
Why PAEL’s outlook just got brighter?
Pak Elektron Limited (PAEL) is revving up for a significant year. With a target gross revenue of Rs95 billion in CY25—36% growth year-over-year—the company is...
Pakgen Power Enters New Phase as PPA Ends, What Lies Ahead?
Pakgen Power Limited (PKGP) has officially entered a new chapter in its corporate journey. With the early termination of its Power Purchase Agreement (PPA) and...
GHNI suitable for quick capital gains
Ghandhara Industries Limited (GHNI) has broken out of its previous consolidation range. This may be a good opportunity to start accumulating the stock